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The idea that schizophrenia may be associated with structural brain changes is as old as the concept of the disease and may indeed precede its clear definition. In 1857 Griesinger' defined the brain as the site of mental disease. In 1891 Clouston2 wrote of abnormalities of the CNS as a feature of the disorder that he called adolescent insanity and later considered this as part of Kraepelin's concept of dementia praecox,3 which came to be known as schizophrenia. In 1907 Kraepelin4 stated that "the morbid anatomy has disclosed not simple inadequacy of the nervous system but destructive morbid processes as the background of the clinical picture".
Despite the confident assertions of these early workers, nine decades of endeavour have not provided unequivocal evidence of these destructive morbid processes. Kraepelin's work was shortly followed by a histological investigation by Alzheimer5 in which he described cell loss and gliosis in schizophrenia. In 1924 Dunlap6 described a study in which three independent observers made cell counts of the cortical layers in which changes in schizophrenia had been observed by Alzheimer and found no difference between schizophrenic patients and controls. Cellular changes similar to those that had been described in schizophrenia were found in both groups. This study cast doubt over the histopathological study of schizophrenia, which persisted for many years and is evident in later 7 reviews.
Since the 1 920s the issue of structural change in the brain in schizophrenia has been investigated by imaging as well as by pathological studies. 8 found. 17 Many of the schizophrenic patients in that study had been examined during their lifetime in connection with various investigations. 18 22 Historical information had been recorded in detail and clinical, neurological, and psychological state had been assessed in a standardised manner. This report is concerned with the relation between these clinical assessments in schizophrenic patients and the pathological findings.
Method
Brains from the 56 schizophrenic patients and 56 normal controls were weighed fresh, then bisected by a midline sagittal section; one half was frozen at -70°C for subsequent neurochemical study. The remaining half was placed medial surface downwards in a plastic container to avoid distortion artefacts and fixed in 10% formalin for four weeks. Full details of the postmortem procedure, measurements, and histological assessments have already been described. 17 Each brain was coded and later examined without knowledge of the clinical history. Thirty eight of the schizophrenic patients had been included in the original large study of inpatients at Shenley Hospital'8 and some of them survived to be included in later studies.'922 Historical information was recorded for the initial study, but the methods used for the assessments of mental state were the same for all of the investigations and the ratings used for this study were those conducted closest to the patient's death. This interval was never more than three years and in one case was five days. All 38 patients fulfilled the St Louis criteria for schizophrenia.23 At the end of the study, when the neuropathological code numbers were compared with the relevant case histories, it was found that five of the Shenley schizophrenic patients had added neurological complications. Three of these related to previous These patients had also been examined in life, although one was too unwell (near death) when she was first seen to cooperate with mental state examination or cognitive testing, and thus was only assessed for movement (hyperkinetic) disorder.
The assessments were positive features24-available in 32 cases; negative features24-available in 32 cases; cognitive functioning25 -available in 26 cases; and hyperkinetic disorder assessed as present or absent-available in 33 cases. The scale of Krawiecka24 and the test battery of Withers and Hinton25 had been used in the repeated assessments of these patients and could therefore be used for this study, but the assessments of movement disorder were changed'8 19 and the simple assessment of present or absent is the most accurate available to us.
STATISTICAL ANALYSIS
As previously reported,'7 in the prospective cliniconeuropathological comparisons there were five variables that distinguished schizophrenic patients from controls-namely, brain weight, brain length, ventricle size, focal damage, and gliosis. Gliosis and focal damage were related and independent of the other more general brain changes. The intention of this study was to see whether any of these neuropathological changes relate to clinical features (either historical or examination variables). This was done by stepwise regression. For example, the schizophrenic patients were divided into two groups on the basis of whether or not they had focal damage or gliosis, (see Bruton et al 17). Logistic stepwise regression was then used to see whether the membership of these two groups could be predicted from clinical variables (using the statistical package BMDP LR). The clinical variables used were subclassified as: (a) sex, 46ohnstone, Bruton, Crow, Fnith, Owens age, age at first admission, duration of illness; (b) positive features, negative features, premorbid functioning (academic and global); (c) results on Withers and Hinton test (cognitive functioning); (d) birth trauma, head injury; (e) movement disorder (noted as hyperkinetic disorder present or absent); (f) additional variables where information applied to few patients or was otherwise imperfect (the use or not of "other treatments"; a history or not of "peculiar circumstances"; a history or not of generalised illness; a family history of definite or possible schizophrenia).
Because of incomplete data (table 1) these variables were examined in various subsetsnamely, set (a), set (a + b), set (a) + (b) + (c), set (a) + (d), set (a) + (e), set (a) + (f). In the linear regression the model was forced to apply age and sex before any of the other variables, as they are known to be strong determinants of measures such as brain weight and brain length. All results reported are derived from this analysis.
Results

RELATIONS BETWEEN BRAIN WEIGHT AND CLINICAL VARIABLES
There were significant relations between brain weight and age and sex, such that females had lower brain weights than males (p < 0.01) and Women's brains were significantly shorter than those of men (p < 0-01). Also, there were significant associations (p < 0 05) between shorter brains and poorer premorbid global function and between shorter brains and more severe negative symptoms (p < 0-02; Figure) .
RELATIONS BETWEEN VENTRICLE SIZE AND CLINICAL VARIABLES
As expected, there was a significant relation (p < 0.01) between increasing age and greater ventricle size. Otherwise there were no relations between clinical variables and ventricular size.
RELATIONS BETWEEN FOCAL DAMAGE AND CLINICAL VARIABLES AND BETWEEN GLIOSIS AND CLINICAL VARIABLES
When all the samples from schizophrenic patients and controls were examined some degree of localised cerebral pathology (focal damage) was found in 44% of the schizophrenic patients and 21% of controls (p < 0-01). 17 The nature and localisation of such pathology was diverse and included such apparently unrelated entities as degeneration of the substantia nigra, calcification of the hippocampus, a ganglioglioma of the pons, focal softening of the cerebellum, and infarction of the striatum. In the group of 33 schizophrenic patients in the present study, focal damage was significantly related only to sex, being less likely to be found in men (p < 0-02). In the total sample,'7 there was a strong positive relation (p < 0-01) between both cortical and white matter gliosis and the presence of focal damage. In the 33 In that study, however, cognitive decline was associated with negative features. In the present study it was brain length rather than brain weight that was associated with negative features. It is possible that the Withers and Hinton test is simply a more sensitive measure of a long standing intellectual deficit than educational attainment. These questions will not be resolved until larger samples of patients who have been assessed in life can be studied at postmortem examination. There was no relation between focal damage and most historical or examination variables, the only significant association being with sex (females had more focal damage than males, p < 002). In considering these results the two main pathological findings: (a) reduction in brain weight and length and (b) the presence of focal damage, require separate discussion. A reduction in brain weight has been previously reported at postmortem examination'5 16 consistent with some radiological studies2830 suggesting a decrease in brain size.
The small but widely replicated increase in ventricular size that is characteristic of the schizophrenic population in general2l 31 32 may also be explicable as a reduction in cerebral mass. One interpretation of these findings is that they represent a failure of development rather than a degenerative process. Consistent with this view is the presence of morphological changes when all identifiable histopathology has been excluded,'7 and the absence of 48ohnstone, Bruton, Crow, Frith, Owens gliosis in those areas of the temporal lobe in which the morphological changes are most pronounced.3"- '5 In the present study brain weight and length were related to poor premorbid academic and global function, relations that might be explained in terms of an early failure of development. Brain length is clearly likely to depend to some extent on skull size and shape, and there are inconsistent reports of differences in cranial size and shape between schizophrenic patients and controls. 36 By contrast the presence of focal damage was unrelated to aspects of the clinical state (although more often seen in females) and is more difficult to explain in terms of existing publications. In a series of 100 brains of patients with major psychosis, Jellinger37 identified Alzheimer-type changes in 1 1, and evidence of vascular encephalopathy in a further eight, but in a series of 1 17 control brains collected at about the same time, Alzheimer-type changes were present in nine and vascular encephalopathy in 14. Therefore no general relation between schizophrenia and focal changes in the brain (such as might be associated with vascular encephalopathy) was found.
At first glance the findings of the present study offer support to the notion that there are at least two routes to the clinical picture of schizophrenia-one involving reduction in brain weight and length and associated with global and cognitive impairments and with negative features, and the other associated with focal damage and female sex. This interpretation may, however, be incorrect. Although focal damage was varied in nature, much of it was clearly vascular in origin (table 1 and appendix, Bruton et al17) and indeed the stated presence of focal damage was significantly associated with a histopathological judgement of the presence of cerebrovascular disease (p < 0.001). The control group consisted of patients who were examined postmortem because they died suddenly and unexpectedly. Those whose general practice records gave any history of neurological or psychiatric disorder were excluded. Although detailed information is not now available, it is likely that the exclusion criteria included transient vascular episodes. The schizophrenic patients were not screened for disorders of this kind, and it is possible that the increased evidence of focal cerebral damage (especially of a vascular nature) in these patients compared with the controls reflects the mode of selection rather than the schizophrenic process. Furthermore, it seems improbable that cerebrovascular disease present at death (at average age 68 in men and 79 in women) could be causally related to a psychotic disorder typically arising in early adult life. The difference in age of death between men and women may be relevant to the excess of focal damage in the female compared with the male schizophrenic, although no such differences were found in normal controls even though the two groups were closely matched for age and sex. Furthermore, interpretation of these findings must be tempered by the small numbers in the subsets and the large number of comparisons.
In conclusion, we regard it as possible, although not proved, that the excess of focal damage and gliosis in the patient group can be accounted for by factors unrelated to the schizophrenic disease process. This would be consistent with the findings of the present study that gross morphological change (for example, in brain weight and length) is correlated with features of the disease (for example, cognitive impairment and negative symptoms), whereas no clinical correlates of the presence of focal damage have been identified.
